Nordin H, Pedersen L M, Svensson B H, Bliddal H
Reumatologisk afdeling, Kommunehospitalet, København.
Ugeskr Laeger. 1996 May 27;158(22):3141-3.
To assess the prevalence of microalbuminuria in patients with rheumatoid arthritis and its correlation with disease activity and drug treatment, we studied 65 patients with rheumatoid arthritis and 51 sex and age matched control persons. Microalbuminuria was significantly increased in patients with rheumatoid arthritis (27.7%) as compared to 7.8% in the control group. Patients with microalbuminuria had a significantly greater median duration of disease (11.2 v 7.8 years; p < 0.001). We found a significant correlation to C-reactive protein as a marker for disease activity. Also, a significant association to treatment with gold and penicillamine was found. The measurement of microalbuminuria by immunochemical methods represents a simple and sensitive test to detect subclinical renal damage and may be a sensitive indicator of disease activity in patients with rheumatoid arthritis. We suggest its use in the monitoring of patients with rheumatoid arthritis to detect early subclinical renal dysfunction and drug induced renal damage.
为评估类风湿关节炎患者微量白蛋白尿的患病率及其与疾病活动度和药物治疗的相关性,我们研究了65例类风湿关节炎患者和51例年龄及性别匹配的对照者。类风湿关节炎患者的微量白蛋白尿显著增加(27.7%),而对照组为7.8%。微量白蛋白尿患者的疾病中位病程显著更长(11.2年对7.8年;p<0.001)。我们发现其与作为疾病活动度标志物的C反应蛋白显著相关。此外,还发现与金制剂和青霉胺治疗存在显著关联。通过免疫化学方法测定微量白蛋白尿是检测亚临床肾损害的一种简单而敏感的试验,可能是类风湿关节炎患者疾病活动度的一个敏感指标。我们建议将其用于监测类风湿关节炎患者,以检测早期亚临床肾功能不全和药物性肾损害。